Everest Medicines Ltd. (1952)
Market Closed
2 Oct, 08:00 AM
HKEX 
28. 64
HKD -1.5
-4.9768%
12.73B Market Cap
- P/E Ratio
- Div Yield
836,547 Volume
- Eps
30.14 HKD
Previous Close Want to track 1952 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Everest Medicines Ltd. (1952) Statistics
Valuation metrics
Market Cap 12.73B
Enterprise value 9.34B
Trailing P/E (ttm) -159.28
Forward P/E -
PEG ratio -0.49
Price/Sales (ttm) 3.67
Price/Book (mrq) 1.43
Enterprise Value/Revenue 3.88
Enterprise Value/EBITDA 144.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.09M
Average volume (90 days) 8.47M
Price summary
52-Week low 22.7
52-Week high 58.6
Beta -
50-Day moving average 30.42
200-Day moving average 30.5
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.02%
Operating margin -0.05%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 8.1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.25
Total debt (mrq) -
Total Debt/Equity (mrq) 0.38
Current ratio (mrq) 3.77%
Book value per share (mrq) 17.6
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
